Skip to main content

Table 6 Adjusted hazard ratio of in-hospital and 3-year mortality in MDR subgroups

From: Epidemiology and outcomes of multidrug-resistant bacterial infection in non-cystic fibrosis bronchiectasis

 

In-hospital mortality

3-year mortality

Control group

Ref.

 

Ref.

 

MDR subgroups

    

MDR-AB

2.865 (2.024-4.055)

<0.001

2.376 (1.971-2.864)

<0.001

ESBL-E coli

1.816 (0.898-3.672)

0.097

1.204 (0.833-1.741)

0.324

ESBL-KP

2.184 (1.371-3.480)

0.001

2.190 (1.715-2.796)

<0.001

MDR-Pseudomonus

1.856 (1.055-3.265)

0.032

1.525 (1.125-2.066)

0.007

MRSA

2.551 (1.594-4.082)

<0.001

1.611 (1.248-2.080)

0.001

  1. Note AB, Acinetobacter baumannii; ESBL, extended-spectrum-beta-lactamases; KP, Klebsiella pneumoniae; MDR: multidrug- resistant; MRSA, methicillin-resistant Staphylococcus aureus